Recent FDA Indications in Endometrial Cancers

Brian Slomovitz

Gynecologic Oncology Updates: Expert Perspective on Key Trial Findin…

Yale Cancer Center

E. Ratner

Endometrial Cancer: The Current Treatment Landscape

Hope Cottrill

Evolving Molecular Considerations in Endometrial Cancer

Casey Cosgrove

Gestational Trophoblastic Diseases

Keck School of Medicine of USC

S. Walia

Radiotherapy Applications for Gynecological Cancers

Yale Cancer Center

D. Addeo

Reproductive System Cancers: What are the Methods to Improve Cardiom…

Cardiometabolic Health Congress (CMHC)

E. Ko

Surgery in Ovary, Endometrial and Cervical Cancer: Discussions on MI…

Baltic and Eurasia Masterclass in Clinical Oncology

M. Halaška

ASCO® 2024 Summary: "Gynecologic Oncology Updates"

2024 ASCO® Annual Meeting Insights Hub

R. Salani

Hysterectomy: What Needs to be Removed?

Mary Jane Minkin

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"

2024 ASCO® Annual Meeting Insights Hub

E. Hamilton

ESMO 2024 Insights: Final OS With Niraparib as 1L Maintenance in Adv…

2024 ESMO Annual Meeting Insights Hub

B. Monk

Year in Review 2024 - Ovarian Cancer

Oncology 2024 Year in Review

E. Crane

ESMO 2024 Summary: dMMR Advanced/Recurrent Endometrial Cancer - Adva…

2024 ESMO Annual Meeting Insights Hub

M. Raza Mirza

Year in Review 2024 - Endometrial Cancer

Mansoor Raza Mirza

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

ASCO® 2024 Summary: "Gynecological Cancers Highlights"

2024 ASCO® Annual Meeting Insights Hub

M. Raza Mirza

ESMO 2024 Insights: Pembro or Placebo in Combination With Adjuvant C…

2024 ESMO Annual Meeting Insights Hub

B. Slomovitz

ESMO 2024 Insights: Rucaparib +/- Nivo as Maintenance in Newly Diagn…

2024 ESMO Annual Meeting Insights Hub

B. Monk

ESMO 2024 Summary: Advances in Cervical Cancer Management - Comprehe…

2024 ESMO Annual Meeting Insights Hub

D. Lorusso